In this first episode of the Better Science Better Health podcast, Gwen and Petra press pause on a clip from the Vital Health Podcast and unpack what is really being said, without the policy fog or economist smoke machine.

Together, they explore why drug pricing has become such a battleground, what MFN actually means in practice, and how the rules governments choose can ripple through the whole system, shaping everything from competition and innovation to which medicines make it to patients in the first place. It is part decoder ring, part conversation, with the thorny bits translated into plain English and the bigger picture brought into focus.